252 related items for PubMed ID: 12699440
21. HYDROCORTISONE THERAPY AND GROWTH TRAJECTORY IN CHILDREN WITH CLASSICAL CONGENITAL ADRENAL HYPERPLASIA.
Bizzarri C, Improda N, Maggioli C, Capalbo D, Roma S, Porzio O, Salerno M, Cappa M.
Endocr Pract; 2017 May; 23(5):546-556. PubMed ID: 28225306
[Abstract] [Full Text] [Related]
22. Ambulatory blood pressure and subclinical cardiovascular disease in patients with congenital adrenal hyperplasia: a preliminary report.
Akyürek N, Atabek ME, Eklioğlu BS, Alp H.
J Clin Res Pediatr Endocrinol; 2015 Mar; 7(1):13-8. PubMed ID: 25800471
[Abstract] [Full Text] [Related]
23. Cardiovascular abnormalities and impaired exercise performance in adolescents with congenital adrenal hyperplasia.
Marra AM, Improda N, Capalbo D, Salzano A, Arcopinto M, De Paulis A, Alessio M, Lenzi A, Isidori AM, Cittadini A, Salerno M.
J Clin Endocrinol Metab; 2015 Feb; 100(2):644-52. PubMed ID: 25405496
[Abstract] [Full Text] [Related]
24. IGF-I-IGFBP-3-acid-labile subunit (ALS) complex in children and adolescents with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CAH).
Völkl TM, Rauh M, Schöfl C, Dörr HG.
Growth Horm IGF Res; 2011 Aug; 21(4):191-8. PubMed ID: 21636299
[Abstract] [Full Text] [Related]
25. Cardiovascular risk factors in children and adolescents with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Subbarayan A, Dattani MT, Peters CJ, Hindmarsh PC.
Clin Endocrinol (Oxf); 2014 Apr; 80(4):471-7. PubMed ID: 23751160
[Abstract] [Full Text] [Related]
26. Growth pattern of untreated boys with simple virilizing congenital adrenal hyperplasia indicates relative androgen insensitivity during the first six months of life.
Bonfig W, Schwarz HP.
Horm Res Paediatr; 2011 Apr; 75(4):264-8. PubMed ID: 21196707
[Abstract] [Full Text] [Related]
27. Congenital Adrenal Hyperplasia in Children: The Relationship between Plasma Renin Activity and Hypertension.
Lubis SM, Soesanti F, Hidayati EL, Aap BT.
Iran J Med Sci; 2024 Jun; 49(6):377-383. PubMed ID: 38952640
[Abstract] [Full Text] [Related]
28. Bone mineral density and body composition in congenital adrenal hyperplasia.
Cameron FJ, Kaymakci B, Byrt EA, Ebeling PR, Warne GL, Wark JD.
J Clin Endocrinol Metab; 1995 Jul; 80(7):2238-43. PubMed ID: 7608286
[Abstract] [Full Text] [Related]
29. Effect of carbenoxolone on the plasma renin activity and hypothalamic-pituitary-adrenal axis in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Irony I, Cutler GB.
Clin Endocrinol (Oxf); 1999 Sep; 51(3):285-91. PubMed ID: 10469007
[Abstract] [Full Text] [Related]
30. [Comparative study of prednisolone versus hydrocortisone acetate for treatment of patients with the classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency].
Leite FM, Longui CA, Kochi C, Faria CD, Borghi M, Calliari LE, Monte O.
Arq Bras Endocrinol Metabol; 2008 Feb; 52(1):101-8. PubMed ID: 18345402
[Abstract] [Full Text] [Related]
31. Growth pattern during the first 36 months of life in congenital adrenal hyperplasia (21-hydroxylase deficiency).
Gasparini N, Di Maio S, Salerno M, Argenziano A, Franzese A, Tenore A.
Horm Res; 1997 Feb; 47(1):17-22. PubMed ID: 9010713
[Abstract] [Full Text] [Related]
32. Cardiovascular and metabolic risk in pediatric patients with congenital adrenal hyperplasia due to 21 hydroxylase deficiency.
Mooij CF, van Herwaarden AE, Sweep FCGJ, Roeleveld N, de Korte CL, Kapusta L, Claahsen-van der Grinten HL.
J Pediatr Endocrinol Metab; 2017 Aug 28; 30(9):957-966. PubMed ID: 28787274
[Abstract] [Full Text] [Related]
33. Gender related differences in glucocorticoid therapy and growth outcomes among pubertal children with 21-hydroxylase deficiency congenital adrenal hyperplasia (CAH).
Deslauriers JR, Lenz AM, Root AW, Diamond FB, Bercu BB.
J Pediatr Endocrinol Metab; 2012 Aug 28; 25(9-10):977-81. PubMed ID: 23426829
[Abstract] [Full Text] [Related]
34. Blood pressure in the first year of life in children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a pilot study.
Mooij CF, Kapusta L, Otten BJ, Claahsen-van der Grinten HL.
Horm Res Paediatr; 2010 Aug 28; 74(5):328-32. PubMed ID: 20357427
[Abstract] [Full Text] [Related]
35. Serum cortisol and 17-hydroxyprogesterone interrelation in classic 21-hydroxylase deficiency: is current replacement therapy satisfactory?
Charmandari E, Matthews DR, Johnston A, Brook CG, Hindmarsh PC.
J Clin Endocrinol Metab; 2001 Oct 28; 86(10):4679-85. PubMed ID: 11600525
[Abstract] [Full Text] [Related]
36. Metabolic profile, cardiovascular risk factors and health-related quality of life in children, adolescents and young adults with congenital adrenal hyperplasia.
Vijayan R, Bhavani N, Pavithran PV, Nair V, Menon UV, Menon AS, Abraham N, Bhadran K, Narayanan P, Kumar H.
J Pediatr Endocrinol Metab; 2019 Aug 27; 32(8):871-877. PubMed ID: 31271560
[Abstract] [Full Text] [Related]
37. Treatment of congenital adrenal hyperplasia in children aged 0-3 years: a retrospective multicenter analysis of salt supplementation, glucocorticoid and mineralocorticoid medication, growth and blood pressure.
Neumann U, van der Linde A, Krone RE, Krone NP, Güven A, Güran T, Elsedfy H, Poyrazoglu S, Darendeliler F, Bachega TASS, Balsamo A, Hannema SE, Birkebaek N, Vieites A, Thankamony A, Cools M, Milenkovic T, Bonfig W, Costa EC, Atapattu N, de Vries L, Guaragna-Filho G, Korbonits M, Mohnike K, Bryce J, Ahmed SF, Voet B, Blankenstein O, Claahsen-van der Grinten HL.
Eur J Endocrinol; 2022 Apr 11; 186(5):587-596. PubMed ID: 35290211
[Abstract] [Full Text] [Related]
38. The relation of peripubertal and pubertal growth to final adult height in children with classic congenital adrenal hyperplasia.
Bomberg EM, Addo OY, Kyllo J, Gonzalez-Bolanos MT, Ltief AM, Pittock S, Himes JH, Miller BS, Sarafoglou K.
J Pediatr; 2015 Mar 11; 166(3):743-50. PubMed ID: 25557963
[Abstract] [Full Text] [Related]
39. Normal ambulatory blood pressure in young adults with 21-hydroxylase enzyme deficiency undergoing glucocorticoid replacement therapy.
Borges JH, Camargo DA, Sewaybricker LE, Santoro RI, de Oliveira DM, de Lemos-Marini SHV, Geloneze B, Guerra G, Gonçalves EM.
Arch Endocrinol Metab; 2023 Jan 18; 67(1):64-72. PubMed ID: 35929901
[Abstract] [Full Text] [Related]
40. Long-term Growth in Congenital Adrenal Hyperplasia.
Maheshwari A, Khadilkar V, Gangodkar P, Khadilkar A.
Indian J Pediatr; 2019 Feb 18; 86(2):154-158. PubMed ID: 30097840
[Abstract] [Full Text] [Related]
Page: [Previous] [Next] [New Search]
